84 results
8-K
EX-99.1
BRSF
Brain Scientific Inc.
2 Nov 22
Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
5:56pm
; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans
D
y81i65mvwpqknqjkn55
19 Jul 22
$5.15M in debt / options, sold $5.15M, 11 investors
12:59pm
DEF 14C
bgtouunb2t
5 Jul 22
Information statement
11:02am
PRE 14C
hqxhmj
24 Jun 22
Preliminary information
12:36pm
8-K
EX-99.1
2l2x71ubelqlv
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-10.1
jm3e o5rrok65zf
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-99.1
w55a608q9nnb7d35
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
b4yp91e1uzhhb5x
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
EX-10.1
hq6f4kvpm510bvm
16 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
mycz6bx8qr4twww8jtg
13 Jan 22
Regulation FD Disclosure
5:28pm
8-K
EX-99.1
qpb9x jxea6t
13 Jan 22
Regulation FD Disclosure
5:28pm
D
lffzuqwbv74sgibs
13 Jan 22
$20M in debt / options, sold $9.66M, 13 investors
4:33pm
8-K
EX-10.1
r0nwovy8
28 Dec 21
Entry into a Material Definitive Agreement
4:18pm
8-K/A
EX-99.2
zwdfeo64yuok5wijl
15 Dec 21
Audited Consolidated Financial Statements
10:49am